Doxorubicin Hydrochloride Liposome Inaliti
Inkcazo elifutshane:
Ingcaciso yeMveliso
Doxorubicin Hydrochloride Liposome Inaliti can be used for low CD4 (3) kwaye sisifo ebanzi visceral zezintsu isifo kwanangezibilini walandisa HIV AIDS AIDS / - izigulane KS. Doxorubicin Hydrochloride Liposome Inj ection can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients: vincristine, bleomycin and doxorubicin.
Drug Igama
Igama Generic. Doxorubicin Hydrochloride Liposome Inj ection
IsiNgesi Igama. Doxorubicin Hydrochloride Liposome Inaliti
Ezinto Formular. C 27H 29NO 11HCl
Weight eziphilayo. 579,99
Doxorubicin Hydrochloride Liposome Inaliti inkcazelo
Le mveliso libomvu semitransparent ukumiswa mixed .
Doxorubicin Hydrochloride Liposome Injection Iimpawu
1. This product can be used for low CD4 (3) kwaye sisifo ebanzi visceral zezintsu isifo kwanangezibilini walandisa HIV AIDS AIDS / - izigulane KS.
2. Le mveliso ingasetyenziswa njengoko lokuqala-line amayeza chemotherapy systemic okanye njengoko lodidi lwesibini amachiza ichemotherapy yonyango progression kwizigulane AIDS-KS, nayo ingasetyenziswa ungenako ukubathwala indibaniselwano ichiza izigulane ezingaphezulu kwama ezimbini ichemotherapy elandelayo : vincristine, bleomycin kunye doxorubicin (okanye enye anthracycline antibiotics).
Doxorubicin Hydrochloride Liposome Inaliti Product Izithombe
Ukucaciswa
20 mg/10 ml
Packaging
1 bottle/box
Amalungiselelo
I-injekshini